KR20200031229A
|
|
Composition comprising fragmented DNA mixture and chitosan for preventing or treating of atopic dermatitis
|
KR20190106140A
|
|
Fluid composition containing higher concentrations of fragmented DNA mixtures and a method for manufacturing the same
|
KR101959523B1
|
|
Composition comprising nucleic acids, bone graft materials and cationic polymers for bone grafting and kit for manufacturing the same
|
KR20190062760A
|
|
Core-shell structured hyaluronic acid gel through double-crosslink and method for preparing the same
|
KR20190062758A
|
|
Core-shell structured hyaluronic acid gel having varying property in accordance with strength of stimulus and method for preparing the same
|
KR20190059609A
|
|
Hyaluronic acid gel through double-crosslink and method for preparing the same
|
KR20190044240A
|
|
Composition for evaluating calcification caused by composion of hyaluronic acid filler and method for in vitro evaluating using the same
|
KR20190033264A
|
|
Method for evaluating side effects of implantable medical device
|
KR20190029108A
|
|
Microneedle array comprising mixture of DNA fragments
|
KR20180110863A
|
|
Composition comprising DNA fragment mixture for preventing or treating of atopic dermatitis
|
KR20180110408A
|
|
Health functional food composition comprising DNA fragment mixture for improving skin beauty
|
WO2018021637A1
|
|
Composition including nucleic acid and chitosan, for repairing rotator cuff tear
|
KR20180013664A
|
|
Composition comprising nucleic acid and chitosan for repair of rotator cuff tear
|
WO2018038331A1
|
|
Composition for articular cavity injection comprising nucleic acid and chitosan
|
KR20180023771A
|
|
Injectable composition comprising nucleic acid and chitosan for articular cavity
|
KR20180035032A
|
|
Injectable composition comprising cross-linked hyaluronic acid
|
KR101708767B1
|
|
Medicine injection apparatus for artificial skin
|
KR101710615B1
|
|
Dermal matrix for transplantation having improved survival rate and method for preparing thereof
|
KR101805761B1
|
|
Spray formulation for mucous membrane containing polydeoxyribonucleotide
|
KR101779393B1
|
|
Microneedle array comprising nucleic acid and manufacture method thereof
|